 |
|
Home | Biogen Idec Receives Consensus Recommendation of “Buy” from Brokerages (NASDAQ:BIIB) |
 |
Biogen Idec Receives Consensus Recommendation of “Buy” from Brokerages (NASDAQ:BIIB)
|
 |
- August 17, 2014
-
Biogen Idec (NASDAQ:BIIB) has been given a consensus recommendation of “Buy” by the twenty-four brokerages that are covering the company, Stock Ratings Network reports. Four analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company. The average 1-year target price among brokerages that have covered the […]This article (Biogen Idec Receives Consensus Recommendation of “Buy” from Brokerages (NASDAQ:BIIB)) was originally developed by and is property of American Banking News.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
- Read more at:http://www.americanbankingnews.com/2014/08/17/biogen-idec-receives-consensus-recommendation-of-buy-from-brokerages-nasdaqbiib/
|
 |
|
 |
|
 |
